Analysis of the Distribution Pattern of Genetic Biomarkers of Safety of Etiotropic Drugs for the Treatment of COVID-19 in Representatives of Ethnic Groups of the Volga Region and the Far East
The effectiveness and safety of favipiravir may be determined by polymorphisms of genes encoding enzymes involved in the biotransformation of the drug — AOX1 and CYP1A2. The aim of the study was to analyze the distribution frequency of allelic variants of genes encoding enzymes involved in the biotr...
Saved in:
| Main Authors: | S. N. Tuchkova, Sh. P. Abdullaev, N. P. Denisenko, A. V. Kryukov, I. I. Temirbulatov, S. S. Suleymanov, E. Y. Kitaeva, V. V. Shprakh, E. E. Sidukova, I. V. Sychev, K. B. Mirzaev, D. A. Sychev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2025-02-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/1182 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment
by: I. I. Temirbulatov, et al.
Published: (2023-10-01) -
Prevalence of AOX1 and CYP1A2 gene polymorphisms associated with response to favipiravir therapy in novel coronavirus infection COVID-19 among ethnic groups of the North Caucasus
by: A. T. Leinsoo, et al.
Published: (2025-07-01) -
A Model for Predicting the Risk of Developing Drug-Induced Liver Injury During Therapy with Favipiravir
by: Yu. V. Shevchuk, et al.
Published: (2025-02-01) -
Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thrombosis
by: l. V. Fedina, et al.
Published: (2024-03-01) -
Association of CYP3A4*1B, CYP3A4*22 and CYP3A5*3 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia
by: Sh. P. Abdullaev, et al.
Published: (2024-05-01)